oncostance.mystrikingly.com Open in urlscan Pro
143.204.215.16  Public Scan

Form analysis
1 forms found in the DOM

POST /i/oncostance/collected_emails.jsm

<form class="new_collected_email" id="new_collected_email" action="/i/oncostance/collected_emails.jsm" accept-charset="UTF-8" method="post"><input name="utf8" type="hidden" value="✓">
  <div class="inputs" data-bind="template: { name: 'emailFormTemplate2', data: email1}">
    <div class="signup-form-container">
      <div class="form s-form-not-success" data-bind="visible: !isSuccess()">
        <div class="fields-container">
          <div class="input" data-bind="visible: hasNameBox()">
            <label class="outside" data-bind="text: name_label" for="collected_email[name]">Name</label>
            <input name="collected_email[name]" type="text">
            <div class="error s-form-error-name" data-bind="visible: isNameEmpty()" style="display: none;"> Please enter a name. </div>
          </div>
          <div class="input" data-bind="visible: hasEmailBox()">
            <label class="outside" data-bind="text: email_label" for="collected_email[email]">Email</label>
            <input name="collected_email[email]" type="text">
            <div class="error s-form-error-email" data-bind="visible: isEmailInvalid()" style="display: none;"> Invalid email. </div>
          </div>
          <div class="input submit">
            <input class="submit-button button s-form-click" data-bind="mouseclick: submit, value: submit_label" type="button" value="Submit">
            <div class="loading-icon s-form-icon" data-bind="visible: isLoading()" style="display: none;"></div>
          </div>
        </div>
      </div>
      <div class="hint s-form-submit-message s-form-success thanks" data-bind="visible: isSuccess(), html: thanksMessage" style="display: none;">Thanks for your subscription!</div>
    </div>
  </div>
  <input data-bind="value:email1.recipient" type="hidden" name="collected_email[recipient]" id="collected_email_recipient"
    value="@@V1aVNPYWgzYjFyVGs0b2VOeFFwUjVkRTU3RU1iNndwaWRyWTFIbVlMVDQ1Yz0tLWtaMklmY2h3VzMzWnBKazYzVDBNVkE9PQ==--cbcd0974da032a7d149e4b60556380960fba0cbc">
  <input data-bind="value:email1.hide_email" type="hidden" value="false" name="collected_email[skip_email]" id="collected_email_skip_email">
  <input data-bind="value:email1.hide_name" type="hidden" value="false" name="collected_email[skip_name]" id="collected_email_skip_name">
  <input data-bind="value:email1.hide_phone_number" type="hidden" value="true" name="collected_email[skip_phone_number]" id="collected_email_skip_phone_number">
  <div class="input" style="display:none;">
    <label class="outside">Comment</label>
    <label class="overlay">Comment</label>
    <input name="_comment" type="text">
  </div>
</form>

Text Content

Homescreen Our vision Oncostance Assay Our team Healthcare trends Our sponsors
Newsletter Contact us




 *  
   
   
   WE ENHANCE CANCER MANAGEMENT
   
   BY LOCAL IMMUNE ASSESSMENT
   
   

 * 
   
   OUR VISION
   
   We believe that a significant change is ongoing in the way patients with
   cancer are followed: practices are now moving from a general medicine that is
   "tumor-centric" to a precision medicine that also considers the "patient"
   ability to fight against the tumor. 
   
    
   
   To make this change happen, industrials need to offer new solutions in
   Immuno-diagnostics and therapeutics.
   
    
   
   In immuno-diagnostics, OncoStance is the first company developing tests that
   can measure the intensity of the immune response in patients who underwent
   cancer surgery. By using OncoStance patient-centric tests in addition to the
   usual tumor-centric prognostic tests, oncologists will be able to better
   predict the disease evolution and to take a more suited therapeutic decision
   for each patient.
   

 * THE ONCOSTANCE ASSAY
   
   OUR MISSION: ENHANCE CANCER MANAGEMENT
   
   THE ONCOSTANCE ASSAY IS FULLY INTEGRATED IN CURRENT & FUTURE MEDICINE
   PRACTICE
   
   Backed by more than 3,000 research articles, we give insights to oncologists,
   surgeons, and pathologists to help them adjust their prescription to each
   patient
   
   
 * OUR TEAM
   
    
   DR. DAVID TEBOUL
   
   CEO & Co Founder
   David is an entrepreneur in digital & health area. He has worked in technical
   & innovation consulting for years after his MBA in Biotechnology Management
   and his PhD in Life Sciences.
    
   Follow @DavidTPhD
   Connect with David on LinkedIn 
   David landing page
    
    
   PR. JEAN-FRANÇOIS EMILE
   
   Scientific & Clinical Co Founder
   
   Professor of pathology and head of research unit in digestive and cutaneous
   tumors in University. Head of pathology department in hospital. Coauthor of
   +250 scientific publications. Innovation inventor & devoted to making
   scientific research useful to patients!
    
    
   DR. CÉLINE EPAULE
   
   Quality & Market Acces Co Founder
   
   Céline is a pharmacist and a PhD candidate in Nanomedicine.
    
   Connect on LinkedIn
    
    
 * TRENDS IN HEALTHCARE & ONCOSTANCE NEWS
   
   DISCOVER THE NEW TECHNOLOGIES IN DIGITAL HEALTH & ONCOSTANCE CORPORATE NEWS
   
    
   Venez nous rencontrer lors d'APinnov 2015 !
   June 5, 2015
   Nous serons présents lors des 12ème journées de l'Innovation dédiée au
   transfert des technologies des Hôpitaux de Paris. Si vous souhaitez en
   profiter pour prendre un rendez-vous  ou simplement partager un café,
   n'hésitez pas à nous en informer !
    
   Get in touch with OncoStance at the Differential Medicine conference!
   December 4, 2014
   OncoStance will attend at "Differential Medecine", an international
   conference held in Paris. You can find informations at
   www.differentialmedicine.com  Don't hesited to come and engage
   conversations, we hope to see you there!
    
   OncoStance lauréat de l'appel à projets de Cancer Campus
   December 4, 2014
   Ce fût le 18 novembre 2014 dans un grand hôtel parisien que le projet
   OncoStance a remporté le premier appel à projets de Cancer Campus ! Les
   échanges furent passionnés et passionnants lors du grand oral avec un
   prestigieux jury composé d’éminents représentants de : Sanofi
   et Ipsen (compagnies...
   « Newer  
    * 
   
     Older »
 * OUR SPONSORS
   
   PARTNERS, INSTITUTIONS AND CORPORATIONS
   
   
   
 * 
   
   
   WANT TO GET THE LASTEST NEWS FROM ONCOSTANCE IN YOUR INBOX?
   
   SUBSCRIBE TO OUR NEWSLETTER
   
   
   Name
   Please enter a name.
   Email
   Invalid email.
   
   Thanks for your subscription!
   Comment Comment
   
   
 * WANT TO CONTACT US?
   
   YOU'VE GOT A QUESTION? YOU WANT TO GET IN TOUCH WITH THE TEAM? LET'S TALK!
   
   
   
   
   oncostance [a]gmail.com
   
   
   
   
   
   
   /OncoStance
   
   
   
   
   
   
   @OncoStance
   
   
   




 * 
 * 
 * 
 * 
 * 

© 2015 OncoStance
responsive website templates

Create your own website with Strikingly
Powered by Strikingly - Free website builder
Powered by Strikingly - Free website builder

   Homescreen Our vision Oncostance Assay Our team Healthcare trends Our
   sponsors Newsletter Contact us
   
 * Powered By